From Our Partners
Thursday, July 7, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Xenex Tests Germ-Zapping Robot Against Live Ebola and Anthrax

by Global Biodefense Staff
November 17, 2015

To validate how the Xenex Germ-Zapping Robot™ can be used for the decontamination of facilities, vehicles and equipment affected by a natural or intentional outbreak, Xenex Disinfection Services recently tested its device against live Ebola virus and Bacillus anthracis (anthrax) spores in collaboration with the biosafety level 4 (BSL-4) containment laboratory at Texas Biomedical Research Institute.

The robot pulses intense UV light covering the entire UV spectrum, destroying viruses, bacteria and bacterial spores in a five-minute disinfection cycle without contact or chemicals.

The live agent study validated the efficacy of pulsed xenon UV light disinfection technology on two of the world’s deadliest pathogens.

In Texas Biomed’s BSL-4 lab, the Xenex robot destroyed both Ebola and anthrax spores on surfaces, achieving a greater than four-log reduction of Ebola in one minute and a greater than three-log reduction in anthrax spores in 15 minutes.

In none of the time/distance combinations was either anthrax or Ebola detected after the Xenex device was utilized.

“Xenex is an evidence-based company and this testing further validates that the Xenex Germ-Zapping Robot™ can be a critically important ally in the battle to stop the spread of high risk pathogens, especially as antibiotic resistance continues to mount,” said Dr. Mark Stibich, Chief Scientific Officer, Xenex.

More than 300 hospitals, Veterans Affairs, Department of Defense, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities in the U.S., Europe, Canada and Africa use Xenex robots.

Source: Xenex press release, adapted.

From Our Partners
Tags: AnthraxBiosafetyBioterrorismEbola

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Biodefense Headlines – 5 July 2022

Biodefense Headlines – 5 July 2022

July 5, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC